{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:40:38Z","timestamp":1785598838229,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province of China","doi-asserted-by":"crossref","award":["ZD2017015"],"award-info":[{"award-number":["ZD2017015"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10557-024-07569-x","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T03:01:47Z","timestamp":1715137307000},"page":"749-763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["LncRNA Gm15834 Aggravates Cardiac Hypertrophy by Interacting with Sam68 and Activating NF-\u03baB Mediated Inflammation"],"prefix":"10.1007","volume":"39","author":[{"given":"Yongsheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meitian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1958-1816","authenticated-orcid":false,"given":"Hongli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"key":"7569_CR1","unstructured":"Heron M, Anderson RN. Changes in the leading cause of death: recent patterns in heart disease and cancer mortality. NCHS Data Brief. 2016;(254):1\u20138."},{"key":"7569_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ejhf.705","volume":"19","author":"HN Sabbah","year":"2017","unstructured":"Sabbah HN. Silent disease progression in clinically stable heart failure. Eur J Heart Fail. 2017;19:469\u201378. https:\/\/doi.org\/10.1002\/ejhf.705.","journal-title":"Eur J Heart Fail"},{"key":"7569_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ejphar.2010.09.018","volume":"649","author":"Z Xiong","year":"2010","unstructured":"Xiong Z, Sun G, Zhu C, et al. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-\u03baB signaling. Eur J Pharmacol. 2010;649:277\u201384. https:\/\/doi.org\/10.1016\/j.ejphar.2010.09.018.","journal-title":"Eur J Pharmacol"},{"key":"7569_CR4","doi-asserted-by":"publisher","first-page":"114100","DOI":"10.1016\/j.bcp.2020.114100","volume":"178","author":"Z Ma","year":"2020","unstructured":"Ma Z, Qin X, Zhong X, et al. Flavine adenine dinucleotide inhibits pathological cardiac hypertrophy and fibrosis through activating short chain acyl-CoA dehydrogenase. Biochem Pharmacol. 2020;178:114100. https:\/\/doi.org\/10.1016\/j.bcp.2020.114100.","journal-title":"Biochem Pharmacol"},{"key":"7569_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2020.04.014","volume":"153","author":"GK Raut","year":"2020","unstructured":"Raut GK, Manchineela S, Chakrabarti M, et al. Imine stilbene analog ameliorate isoproterenol-induced cardiac hypertrophy and hydrogen peroxide-induced apoptosis. Free Radic Biol Med. 2020;153:80\u20138. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.04.014.","journal-title":"Free Radic Biol Med"},{"key":"7569_CR6","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1038\/onc.2011.621","volume":"31","author":"R Spizzo","year":"2011","unstructured":"Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 2011;31:4577\u201387. https:\/\/doi.org\/10.1038\/onc.2011.621.","journal-title":"Oncogene"},{"key":"7569_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fgene.2015.00002","volume":"6","author":"AF Palazzo","year":"2015","unstructured":"Palazzo AF, Lee ES. Non-coding RNA: what is functional and what is junk? Front Genet. 2015;6:2. https:\/\/doi.org\/10.3389\/fgene.2015.00002.","journal-title":"Front Genet"},{"key":"7569_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/543183a","volume":"543","author":"K Adelman","year":"2017","unstructured":"Adelman K, Egan E. Non-coding RNA: more uses for genomic junk. Nature. 2017;543:183\u20135. https:\/\/doi.org\/10.1038\/543183a.","journal-title":"Nature"},{"key":"7569_CR9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/CIRCRESAHA.116.302521","volume":"116","author":"S Uchida","year":"2015","unstructured":"Uchida S, Dimmeler S. Long noncoding RNAs in cardiovascular diseases. Circ Res. 2015;116:737\u201350. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.302521.","journal-title":"Circ Res"},{"key":"7569_CR10","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1161\/CIRCULATIONAHA.116.023686","volume":"134","author":"C B\u00e4r","year":"2016","unstructured":"B\u00e4r C, Chatterjee S, Thum T. Long noncoding RNAs in cardiovascular pathology, diagnosis, and therapy. Circulation. 2016;134:1484\u201399. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.023686.","journal-title":"Circulation"},{"key":"7569_CR11","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nm.4179","volume":"22","author":"Z Wang","year":"2016","unstructured":"Wang Z, Zhang XJ, Ji YX, et al. The long noncoding RNA chaer defines an epigenetic checkpoint in cardiac hypertrophy. Nat Med. 2016;22:1131\u20139. https:\/\/doi.org\/10.1038\/nm.4179.","journal-title":"Nat Med"},{"key":"7569_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155\u20139. https:\/\/doi.org\/10.1038\/nrg2521.","journal-title":"Nat Rev Genet"},{"key":"7569_CR13","doi-asserted-by":"publisher","first-page":"D969","DOI":"10.1093\/nar\/gkaa806","volume":"49","author":"J Chen","year":"2021","unstructured":"Chen J, Zhang J, Gao Y, et al. LncSEA: a platform for long non-coding RNA related sets and enrichment analysis. Nucleic Acids Res. 2021;49:D969\u2013d980. https:\/\/doi.org\/10.1093\/nar\/gkaa806.","journal-title":"Nucleic Acids Res"},{"key":"7569_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41467-017-02280-y","volume":"9","author":"CY Liu","year":"2018","unstructured":"Liu CY, Zhang YH, Li RB, et al. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat Commun. 2018;9:29. https:\/\/doi.org\/10.1038\/s41467-017-02280-y.","journal-title":"Nat Commun"},{"key":"7569_CR15","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/CIRCRESAHA.117.312117","volume":"122","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Jiao L, Sun L, et al. LncRNA ZFAS1 as a SERCA2a inhibitor to cause intracellular Ca2+ overload and contractile dysfunction in a mouse model of myocardial infarction. Circ Res. 2018;122:1354\u201368. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.312117.","journal-title":"Circ Res"},{"key":"7569_CR16","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.ymthe.2020.10.024","volume":"29","author":"C Song","year":"2021","unstructured":"Song C, Qi H, Liu Y, et al. Inhibition of lncRNA Gm15834 attenuates autophagy-mediated myocardial hypertrophy via the miR-30b-3p\/ ULK1 axis in mice. Mol Ther. 2021;29:1120\u201337. https:\/\/doi.org\/10.1016\/j.ymthe.2020.10.024.","journal-title":"Mol Ther"},{"key":"7569_CR17","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1074\/jbc.272.6.3129","volume":"272","author":"I Barlat","year":"1997","unstructured":"Barlat I, Maurier F, Duchesne M, Guitard E, Tocque B, Schweighoffer F. A role for Sam68 in cell cycle progression antagonized by a spliced variant within the KH domain. J Biol Chem. 1997;272:3129\u201332. https:\/\/doi.org\/10.1074\/jbc.272.6.3129.","journal-title":"J Biol Chem"},{"key":"7569_CR18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1083\/jcb.200701005","volume":"176","author":"MP Paronetto","year":"2007","unstructured":"Paronetto MP, Achsel T, Massiello A, Chalfant CE, Sette C. The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x. J Cell Biol. 2007;176:929\u201339. https:\/\/doi.org\/10.1083\/jcb.200701005.","journal-title":"J Cell Biol"},{"key":"7569_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00018-004-4309-3","volume":"62","author":"S Najib","year":"2005","unstructured":"Najib S, Mart\u00a8\u00aan-Romero C, Gonz\u00a8\u00a2lez-Yanes C, S\u00a8\u00a2nchez-Margalet V. Role of Sam68 as an adaptor protein in signal transduction. Cell Mol Life Sci. 2005;62:36\u201343. https:\/\/doi.org\/10.1007\/s00018-004-4309-3.","journal-title":"Cell Mol Life Sci"},{"key":"7569_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.molcel.2011.05.007","volume":"43","author":"P Ramakrishnan","year":"2011","unstructured":"Ramakrishnan P, Baltimore D. Sam68 is required for both NF-\u03baB activation and apoptosis signaling by the TNF receptor. Mol Cell. 2011;43:167\u201379. https:\/\/doi.org\/10.1016\/j.molcel.2011.05.007.","journal-title":"Mol Cell"},{"key":"7569_CR21","doi-asserted-by":"publisher","first-page":"e15018","DOI":"10.7554\/eLife.15018","volume":"5","author":"K Fu","year":"2016","unstructured":"Fu K, Sun X, Wier EM, et al. Sam68\/KHDRBS1 is critical for colon tumorigenesis by regulating genotoxic stress-induced NF-\u03baB activation. Elife. 2016;5:e15018. https:\/\/doi.org\/10.7554\/eLife.15018.","journal-title":"Elife"},{"key":"7569_CR22","doi-asserted-by":"publisher","unstructured":"Hall G, Hasday JD, Rogers TB. Regulating the regulator: NF-kappaB signaling in heart. J Mol Cell Cardiol. 2006;41. https:\/\/doi.org\/10.1016\/j.yjmcc.2006.07.006.:580\u2009\u2013\u200991.","DOI":"10.1016\/j.yjmcc.2006.07.006"},{"key":"7569_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.tig.2013.01.004","volume":"29","author":"A Castello","year":"2013","unstructured":"Castello A, Fischer B, Hentze MW, Preiss T. RNA-binding proteins in mendelian disease. Trends Genet. 2013;29:318\u201327. https:\/\/doi.org\/10.1016\/j.tig.2013.01.004.","journal-title":"Trends Genet"},{"key":"7569_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/wrna.1241","volume":"5","author":"CY Chen","year":"2014","unstructured":"Chen CY, Shyu AB. Emerging mechanisms of mRNP remodeling regulation. Wiley Interdiscip Rev RNA. 2014;5:713\u201322. https:\/\/doi.org\/10.1002\/wrna.1241.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"7569_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.carpath.2019.04.005","volume":"42","author":"X Luo","year":"2019","unstructured":"Luo X, He S, Hu Y, Liu J, Chen X. Sp1-induced LncRNA CTBP1-AS2 is a novel regulator in cardiomyocyte hypertrophy by interacting with FUS to stabilize TLR4. Cardiovasc Pathol. 2019;42:21\u20139. https:\/\/doi.org\/10.1016\/j.carpath.2019.04.005.","journal-title":"Cardiovasc Pathol"},{"key":"7569_CR26","doi-asserted-by":"publisher","first-page":"5985","DOI":"10.1002\/jcp.29524","volume":"235","author":"C Chen","year":"2020","unstructured":"Chen C, Liu M, Tang Y, et al. LncRNA H19 is involved in myocardial ischemic preconditioning via increasing the stability of nucleol in protein. J Cell Physiol. 2020;235:5985\u201394. https:\/\/doi.org\/10.1002\/jcp.29524.","journal-title":"J Cell Physiol"},{"key":"7569_CR27","doi-asserted-by":"publisher","first-page":"773381","DOI":"10.3389\/fcell.2021.773381","volume":"9","author":"Z Xu","year":"2021","unstructured":"Xu Z, Mo Y, Li X, et al. The novel LncRNA AK035396 drives cardiomyocyte apoptosis through Mterf1 in myocardial ischemia\/reperfusion injury. Front Cell Dev Biol. 2021;9:773381. https:\/\/doi.org\/10.3389\/fcell.2021.773381.","journal-title":"Front Cell Dev Biol"},{"key":"7569_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1006\/cimm.2001.1851","volume":"212","author":"C Mart\u00a8\u00aan-Romero","year":"2001","unstructured":"Mart\u00a8\u00aan-Romero C, S\u00a8\u00a2nchez-Margalet V. Human leptin activates PI3K and MAPK pathways in human peripheral blood mononuclear cells: possible role of Sam68. Cell Immunol. 2001;212:83\u201391. https:\/\/doi.org\/10.1006\/cimm.2001.1851.","journal-title":"Cell Immunol"},{"issue":"2","key":"7569_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.molcel.2011.07.004","volume":"43","author":"GT Kunkel","year":"2011","unstructured":"Kunkel GT, Wang X. Sam68 guest STARs in TNF-\u03b1 signaling. Mol Cell. 2011;43(2):157\u20138. https:\/\/doi.org\/10.1016\/j.molcel.2011.07.004.","journal-title":"Mol Cell"},{"key":"7569_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/cmi.2016.32","volume":"14","author":"JA Tomalka","year":"2017","unstructured":"Tomalka JA, de Jesus TJ, Ramakrishnan P. Sam68 is a regulator of toll-like receptor signaling. Cell Mol Immunol. 2017;14:107\u201317. https:\/\/doi.org\/10.1038\/cmi.2016.32.","journal-title":"Cell Mol Immunol"},{"key":"7569_CR31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/cvr\/cvp237","volume":"84","author":"L Zelarayan","year":"2009","unstructured":"Zelarayan L, Renger A, Noack C, et al. NF-kappaB activation is required for adaptive cardiac hypertrophy. Cardiovasc Res. 2009;84:416\u201324. https:\/\/doi.org\/10.1093\/cvr\/cvp237.","journal-title":"Cardiovasc Res"},{"key":"7569_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/aps.2017.58","volume":"39","author":"HQ Hong","year":"2018","unstructured":"Hong HQ, Lu J, Fang XL, et al. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-\u03baB signaling pathway. Acta Pharmacol Sin. 2018;39:184\u201394. https:\/\/doi.org\/10.1038\/aps.2017.58.","journal-title":"Acta Pharmacol Sin"},{"key":"7569_CR33","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1590\/s0100-879x2012007500121","volume":"45","author":"GJ Wang","year":"2012","unstructured":"Wang GJ, Wang HX, Yao YS, Guo LY, Liu P. The role of Ca2+\/calmodulin-dependent protein kinase II and calcineurin in TNF-\u03b1-induced myocardial hypertrophy. Braz J Med Biol Res. 2012;45:1045\u201351. https:\/\/doi.org\/10.1590\/s0100-879x2012007500121.","journal-title":"Braz J Med Biol Res"},{"key":"7569_CR34","doi-asserted-by":"publisher","first-page":"e0118759","DOI":"10.1371\/journal.pone.0118759","volume":"10","author":"S Zhang","year":"2015","unstructured":"Zhang S, Tang F, Yang Y, et al. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-\u03baB\/PGC-1\u03b1 signaling mediated energy biosynthesis. PLoS ONE. 2015;10:e0118759. https:\/\/doi.org\/10.1371\/journal.pone.0118759.","journal-title":"PLoS ONE"},{"key":"7569_CR35","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/HYPERTENSIONAHA.118.12267","volume":"73","author":"S Kumar","year":"2019","unstructured":"Kumar S, Wang G, Zheng N, et al. HIMF (hypoxia-induced mitogenic factor)-IL (interleukin)-6 signaling mediates cardiomyocyte-fibroblast crosstalk to promote cardiac hypertrophy and fibrosis. Hypertension. 2019;73:1058\u201370. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.12267.","journal-title":"Hypertension"},{"key":"7569_CR36","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20171438","author":"Y Bai","year":"2018","unstructured":"Bai Y, Sun X, Chu Q, et al. Caspase-1 regulate AngII-induced cardiomyocyte hypertrophy via upregulation of IL-1\u03b2. Biosci Rep. 2018. https:\/\/doi.org\/10.1042\/BSR20171438. BSR20171438.","journal-title":"Biosci Rep"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07569-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-024-07569-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07569-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:02:42Z","timestamp":1753891362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-024-07569-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["7569"],"URL":"https:\/\/doi.org\/10.1007\/s10557-024-07569-x","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,8]]},"assertion":[{"value":"26 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was conducted according to the \u201cGuide for the Care and Use of Laboratory Animals\u201d (NIH publication, 8th Edition, 2011). All animal experiments involved in this subject were approved and agreed by the Ethics Committee of Harbin Medical University-Daqing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Authors give full consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflicts of interest to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}